Mentors
Education and Clinical TrainingBA: 1991, Bucknell UniversityM.D.: 1995, SUNY Upstate Medical Center at Syracuse, NY Residency: 1999, University Hospital, SUNY Health Science Center at Syracuse Clinical SpecialtyPsychiatry, Certified: 2000Clinical Department/Section AffiliationsAssistant Professor, Psychiatry and Behavioral SciencesResearch Program and Department AffiliationsPsychiatry and Behavioral SciencesResearch InterestsDepression and Anxiety Disorders Research ProgramResearch AbstractSelected References Schwartz TL, Masand PS: The Role of Atypical Antipsychotics in the Treatment of Delirium Psychosomatics 43:3;171-174, May-June 2002 Masand PS, Schwartz TL, Alao A: Research Priorities in Electroconvulsive Therapy Archives of Indian Psychiatry. 6(1):176-179 2000 Summer Schwartz TL: The Use of Tiagabine Augmentation for Treatment Resistant Anxiety Disorders: A Case Series. Psychopharmacology Bulletin 36(2):53-57, Spring 2002 Masand PS, Gupta S, Schwartz TL, Virk S, Lockwood K, Hameed A, King M, Kaplan DS: Paroxetine in Patients with Irritable Bowel Syndrome: A Pilot Open-Label Study. Primary Care Companion J Clin Psychiatry. 4(1):12-16 2002. Presented APA Annual Conference 2001, New Orleans, LA Schwartz TL, Leso, L, Beale, M, Ahmed, R, Naprawa, S: Modafinil in the Treatment of Depression with Severe Comorbid Medical Illness Psychosomatics 43:336-337, August 2002 Prakash S. Masand; Thomas L. Schwartz; Xiaohong Wang; Daniel J. Kuhles; Sanja Gupta; Bhushan Agharkar; Jacob Manjooran; M. Ahmad Hameed; William Hardoby; Subhdeep Virk; Bradford Frank. Prescribing Conventional Antipsychotics in the Era of Novel Antipsychotics: Informed Consent Issues. Am J Ther 2002 Nov-Dec;9(6):484-7 Masand PS, Gupta S, Schwartz TL: Does a Pre-existing Anxiety Disorder Predict Response to Paroxetine in IBS? Psychosomatics. 43(6):451-5, 2002 Nov Schwartz TL, Beale M. Psychotropic induced weight gain alleviated with orlistat. Psychopharm Bull 2003; 37(1): 5-8. Schwartz TL, Jindal S, Virk S, Wade M: Safety and Tolerability of the Antidepressant, Venlafaxine XR, in the Severely Medically and Surgically Ill. Presented at 2002 SUNY Upstate Medical University Research Poster Session Presented APA IPS Annual Conference 2003, Boston, MA (In Press) Psychosomatics Malhotra K, Schwartz TL, Hameed U: Is Suicidality a Prognostic Indicator for Major Depression in the Primary Care Setting? Presented at 2002 SUNY Upstate Medical University Research Poster Session. Submitted APA Annual Conference 2003, San Francisco, CA. (In Press) The Journal of Postgraduate Medicine Schwartz TL, Jindal S, Simionescu M, Nihalani N, Azhar N, Tirmazi S, Hussein J: Effectiveness of Orlistat Versus Diet and Exercise for Weight Gain Associated with Antidepressant Use: A Pilot Study. (In Press) Journal of Clinical Psychopharmacology Schwartz TL, Nihalani N, Jindal S, et al. Psychiatric Medication Induced Obesity: An Epidemiologic Review. (In press) Obesity Reviews Schwartz TL, Virk S, Nihalani N, et al. Psychiatric Medication Induced Obesity: An Etiologic Review. (In press) Obesity Reviews Schwartz TL, Azhar N, Hussein J, Jindal S, Hopkins G, Simionescu M, Nihalani N. Modafinal augmentation to reduce fatigue associated with serotonergic antidepressants. Submitted to Journal of Clinical Psychopharmacology Schwartz TL, Nihalani N, Simionescu M, Hopkins G: The pharmacodynamic history of treating anxiety: A review. Submitted to Current Pharmaceutical Design Schwartz TL, Nihalani N, Jindal S, et al. Psychiatric Medication Induced Obesity: Treatment Options. Submitted Obesity Reviews
Publications - link to PubMedNote: The above PubMed link opens a new window. Close the PubMed window to return to this page.Additional InformationDirector, Adult Outpatient Services; Assistant Training Director; Director, Depression and Anxiety Research ProgramThis profile was last updated on 04/10/2007 A short link is available for this profile: |
